Paraspinal Muscle Degeneration: A Potential Risk Factor for New Vertebral Compression Fractures After Percutaneous Kyphoplasty.
new vertebral compression fractures
nomogram
paraspinal muscle degeneration
percutaneous kyphoplasty
risk factors
Journal
Clinical interventions in aging
ISSN: 1178-1998
Titre abrégé: Clin Interv Aging
Pays: New Zealand
ID NLM: 101273480
Informations de publication
Date de publication:
2022
2022
Historique:
received:
16
05
2022
accepted:
02
08
2022
entrez:
22
8
2022
pubmed:
23
8
2022
medline:
24
8
2022
Statut:
epublish
Résumé
The paraspinal muscle is essential for maintaining normal spine function and structure, which degeneration is closely related to various spinal diseases. The main objective of this study was to identify the potential role of paraspinal muscle degeneration in the occurrence of new vertebral compression fractures (NVCF) and develop a clinically applicable nomogram for prospective NVCF risk prediction. A total of 202 patients with single-level osteoporotic vertebral compression fractures (OVCF) who underwent percutaneous kyphoplasty treatment between January 2016 and March 2019 were included in this study. Demographic, clinical, radiological, and treatment data were collected and analyzed. The paraspinal muscle cross-sectional area (CSA) and fat signal fraction (FSF) were measured to quantify the extent of muscle degeneration. Multivariate binary logistic regression analysis was performed to select risk factors to build a nomogram that predicted the occurrence of NVCF. The concordance index (C-index) and calibration curve were used to evaluate the discriminative capacity and predictive accuracy of the nomogram. NVCF occurred in 54 of 202 patients (26.7%). The erector spinae FSF (OR = 1.064; P = 0.001), psoas major FSF (OR = 1.326; P < 0.001), and the difference index of the muscle CSA between multifidus and psoas major (OR = 1.048; P < 0.001) were independent risk factors for the occurrence of NVCF. The nomogram performance was good after evaluation using the calibration curves and C-index (95% confidence interval, 0.854-0.943). Paraspinal muscle degeneration is a potential risk factor for NVCF occurrence. A nomogram was designed to precisely predict the risk of NVCF. This predictive nomogram may help clinicians to make better clinical decisions and provide more accurate functional exercise protocol for OVCF patients.
Sections du résumé
Background
UNASSIGNED
The paraspinal muscle is essential for maintaining normal spine function and structure, which degeneration is closely related to various spinal diseases. The main objective of this study was to identify the potential role of paraspinal muscle degeneration in the occurrence of new vertebral compression fractures (NVCF) and develop a clinically applicable nomogram for prospective NVCF risk prediction.
Methods
UNASSIGNED
A total of 202 patients with single-level osteoporotic vertebral compression fractures (OVCF) who underwent percutaneous kyphoplasty treatment between January 2016 and March 2019 were included in this study. Demographic, clinical, radiological, and treatment data were collected and analyzed. The paraspinal muscle cross-sectional area (CSA) and fat signal fraction (FSF) were measured to quantify the extent of muscle degeneration. Multivariate binary logistic regression analysis was performed to select risk factors to build a nomogram that predicted the occurrence of NVCF. The concordance index (C-index) and calibration curve were used to evaluate the discriminative capacity and predictive accuracy of the nomogram.
Results
UNASSIGNED
NVCF occurred in 54 of 202 patients (26.7%). The erector spinae FSF (OR = 1.064; P = 0.001), psoas major FSF (OR = 1.326; P < 0.001), and the difference index of the muscle CSA between multifidus and psoas major (OR = 1.048; P < 0.001) were independent risk factors for the occurrence of NVCF. The nomogram performance was good after evaluation using the calibration curves and C-index (95% confidence interval, 0.854-0.943).
Conclusion
UNASSIGNED
Paraspinal muscle degeneration is a potential risk factor for NVCF occurrence. A nomogram was designed to precisely predict the risk of NVCF. This predictive nomogram may help clinicians to make better clinical decisions and provide more accurate functional exercise protocol for OVCF patients.
Identifiants
pubmed: 35990803
doi: 10.2147/CIA.S374857
pii: 374857
pmc: PMC9385132
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1237-1248Informations de copyright
© 2022 Si et al.
Déclaration de conflit d'intérêts
All authors declare that they have no conflict of interest.
Références
Arch Gerontol Geriatr. 2015 Sep-Oct;61(2):197-201
pubmed: 26058723
Spine (Phila Pa 1976). 2019 Sep;44(18):1294-1302
pubmed: 30946297
JAMA. 2009 Feb 4;301(5):513-21
pubmed: 19190316
J Orthop Sports Phys Ther. 2008 Mar;38(3):101-8
pubmed: 18349481
J Clin Oncol. 2003 Apr 1;21(7):1232-7
pubmed: 12663709
J Neurotrauma. 2018 Nov 1;35(21):2540-2553
pubmed: 29786465
Spine J. 2019 Feb;19(2):301-305
pubmed: 29959099
Eur Spine J. 2000 Dec;9(6):577-85
pubmed: 11189930
J Nutr Health Aging. 2010 May;14(5):362-6
pubmed: 20424803
Scand J Med Sci Sports. 2015 Dec;25(6):880-7
pubmed: 25134643
Spine (Phila Pa 1976). 1995 Jan 15;20(2):192-8
pubmed: 7716624
Spine (Phila Pa 1976). 2011 Dec 1;36(25):2152-7
pubmed: 21343855
J Appl Physiol (1985). 2015 Jul 1;119(1):27-36
pubmed: 25930028
Radiology. 1978 Oct;129(1):23-9
pubmed: 693884
Spine (Phila Pa 1976). 1993 Jun 1;18(7):830-6
pubmed: 8316880
J Orthop Sports Phys Ther. 2018 Aug;48(8):613-621
pubmed: 29772956
Spine J. 2020 Oct;20(10):1573-1585
pubmed: 32325246
Lancet. 2013 Jan 5;381(9860):47-54
pubmed: 23083889
World Neurosurg. 2017 Mar;99:226-231
pubmed: 27931946
Hip Int. 2021 May;31(3):430-434
pubmed: 31997667
Eur Spine J. 2006 Dec;15(12):1785-95
pubmed: 16819622
J Bone Joint Surg Am. 2009 Jan;91(1):176-85
pubmed: 19122093
Eur Spine J. 2018 Oct;27(10):2650-2659
pubmed: 30155731
Crit Care Med. 2007 Sep;35(9):2052-6
pubmed: 17568333
Nat Neurosci. 2003 Mar;6(3):300-8
pubmed: 12563264
Spine J. 2016 Apr;16(4):451-8
pubmed: 26165478
Spine (Phila Pa 1976). 2001 Jan 15;26(2):151-6
pubmed: 11154534
Eur Spine J. 2000 Aug;9(4):266-72
pubmed: 11261613
Spine J. 2020 Feb;20(2):251-260
pubmed: 31525471
Eur Spine J. 2015 Apr;24(4):737-43
pubmed: 25374300
Maturitas. 2015 Sep;82(1):85-93
pubmed: 26255681
Mol Aspects Med. 2016 Aug;50:56-87
pubmed: 27106402
Spine (Phila Pa 1976). 2013 May 20;38(12):E713-22
pubmed: 23429687
J Bone Miner Res. 1997 Jan;12(1):16-23
pubmed: 9240721
Eur Spine J. 2002 Feb;11(1):89-90
pubmed: 11931072
Scand J Med Sci Sports. 2019 Jul;29(7):980-991
pubmed: 30859637
J Appl Physiol (1985). 2008 Nov;105(5):1498-503
pubmed: 18818386
Front Endocrinol (Lausanne). 2016 Jun 20;7:69
pubmed: 27379021
Eur Spine J. 2013 Jun;22(6):1332-8
pubmed: 23515711